Clinical trials
Withdrawn Phase 2 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 1 |
| Fudan University | 1 |
| Galectin Therapeutics Inc. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Massachusetts General Hospital | 1 |
| National Cancer Institute (NCI) | 1 |
| Samsung Medical Center | 1 |
| Sorrento Therapeutics, Inc. | 1 |
| Sun Yat-sen University | 1 |
| Technical University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 12 |
| Colorectal Neoplasms | 2 |
| Gallbladder Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
| Bile Duct Neoplasms | 1 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.